
Auteur B. K. LOGAN
|
Documents disponibles écrits par cet auteur (10)

C. BANTA-GREEN ; GOLDBAUM G. ; S. KINGSTON ; GOLDEN M. ; HARRUFF R. ; B. K. LOGAN | 2005
Dans Substance Use and Misuse (Vol.40 n°9-10, 2005) Article : PériodiqueENGLISH : Club drug use, MDMA in particular, appeared as a growing problem in the Seattle area in the late 1990s. To understand more about the patterns of MDMA use and to evaluate the current state of MDMA use, multiple data sources were exami[...]
FRANÇAIS : Vingt huit cas de conducteurs, tués ou arrêtés suite à un accident de la route et ayant des tests positifs à la méthamphétamine, sont examinés par rapport aux circonstances de l'accident ou de l'arrestation, aux observations du rapp[...]![]()
E. BARENHOLTZ ; A. J. KROTULSKI ; P. MORRIS ; N. D. FITZGERALD ; A. LE ; D. M. PAPSUN ; B. K. LOGAN ; W. E. HAHN ; B. A. GOLDBERGER ; L. B. COTTLER ; J. J. PALAMAR | 2021
Dans International Journal of Drug Policy (Vol.98, December 2021) Article : PériodiqueBackground: Novel psychoactive substances (NPS) present continuous and growing challenges for the scientific, medical, and interventional communities as emerging substances on recreational drug markets change national and international drug land[...]
J. S. LOVE ; M. LEVINE ; K. ALDY ; J. BRENT ; A. J. KROTULSKI ; B. K. LOGAN ; C. VARGAS-TORRES ; S. E. WALTON ; A. AMADUCCI ; D. CALELLO ; R. HENDRICKSON ; A. HUGHES ; A. KURT ; B. JUDGE ; A. PIZON ; E. SCHWARZ ; J. SHULMAN ; T. WIEGAN ; P. WAX ; A. F. MANINI | 2023
Dans Clinical Toxicology (Vol.61, n°3, March 2023) Article : PériodiqueIntroduction: Illicit opioids, consisting largely of fentanyl, novel synthetic opioids, and adulterants, are the primary cause of drug overdose fatality in the United States. Xylazine, an alpha-2 adrenergic agonist and veterinary tranquilizer, i[...]
B. K. LOGAN ; A. L. A. MOHR ; M. FRISCIA ; A. J. KROTULSKI ; D. M. PAPSUN ; S. L. KACINKO ; J. D. ROPERO-MILLER ; M. A. HUESTIS | 2017
Dans Journal of Analytical Toxicology (Vol.41, n°7, September 2017) Article : PériodiqueNovel psychoactive substances (NPS) represent significant analytical and interpretive challenges to forensic and clinical toxicologists. Timely access to case reports and reports of adverse incidents of impairment or toxicity is imperative to cl[...]
L. M. LABAY ; J. L. CARUSO ; T. P. GILSON ; R. J. PHIPPS ; L. D. KNIGHT ; N. P. LEMOS ; I. M. McINTYRE ; R. STOPPACHER ; L. M. TORMOS ; A. L. WIENS ; E. WILLIAMS ; B. K. LOGAN | 2016
Dans Forensic Science International (Vol.260, March 2016) Article : PériodiqueAdverse effects associated with synthetic cannabinoid use include agitation, psychosis, seizures and cardiovascular effects, all which may result in a lethal outcome. We report the collection of data from 25 medical examiner and coroner cases wh[...]
International Council on Alcohol, Drugs and Traffic Safety, Organisateur de réunion ; TIAFT, Organisateur de réunion ; B. K. LOGAN ; D. S. ISENSCHMID ; J. M. WALSH ; D. BEIRNESS ; J. MORLAND | 2007
Congrès
A. J. KROTULSKI ; A. CANNAERT ; C. STOVE ; B. K. LOGAN | 2021
Dans Drug Testing and Analysis (Vol.13, n°2, February 2021) Article : PériodiqueA new class of synthetic cannabinoids has emerged as new psychoactive substances (NPS). Similar in structure to JWH-022, these substances contain alkene modifications to the tail region of the synthetic cannabinoid core structure, and nomenclatu[...]
A. L. A. MOHR ; M. FRISCIA ; J. K. YEAKEL ; B. K. LOGAN | 2018
Dans Forensic Science International (Vol.282, January 2018) Article : PériodiqueNovel psychoactive substances (NPS), often characterized as unregulated psychoactive compounds designed to circumvent existing legislation, have become mainstream on the illicit drug market. Because of their physical and mind-altering properties[...]